The North America Artificial Intelligence in Diagnostics Market is expected to witness market growth of 20.7% CAGR during the forecast period (2024-2031).
The US market dominated the North America Artificial Intelligence in Diagnostics Market by country in 2023, and is expected to continue to be a dominant market till 2031; thereby, achieving a market value of $1.90 billion by 2031. The Canada market is experiencing a CAGR of 23.1% during 2024-2031. Additionally, the Mexico market is expected to exhibit a CAGR of 22.2% during 2024-2031.
AI-based dermatology applications use deep learning algorithms to analyze skin images to detect skin diseases, including melanoma, eczema, and psoriasis. Mobile apps powered by AI allow users to perform preliminary skin assessments, improving early diagnosis and treatment accessibility. AI enhances eye disease diagnosis by analyzing retinal scans to detect conditions such as diabetic retinopathy, glaucoma, and macular degeneration. AI-driven eye screening tools provide quick and accurate results, improving early detection and intervention.
Additionally, multiple factors are driving the adoption of AI in diagnostics. The rapid development of deep learning, computer vision, and natural language processing (NLP) has significantly improved the accuracy and efficiency of AI-driven diagnostic tools. AI automates image analysis and decision-making processes by addressing the global shortage of skilled radiologists, pathologists, and other diagnostic specialists.
In Canada, the government’s $196.1 billion investment over ten years, including $46.2 billion in new funding for provinces and territories, will significantly enhance healthcare infrastructure, digital health initiatives, and AI-driven diagnostics. This investment will promote early disease detection, predictive analytics, and AI-powered imaging solutions, improving patient outcomes and reducing diagnostic delays. Additionally, the $2.5 billion allocation for Indigenous healthcare will expand AI-based telemedicine and remote diagnostics, ensuring equitable access to advanced healthcare technologies across underserved communities.
The US market dominated the North America Artificial Intelligence in Diagnostics Market by country in 2023, and is expected to continue to be a dominant market till 2031; thereby, achieving a market value of $1.90 billion by 2031. The Canada market is experiencing a CAGR of 23.1% during 2024-2031. Additionally, the Mexico market is expected to exhibit a CAGR of 22.2% during 2024-2031.
AI-based dermatology applications use deep learning algorithms to analyze skin images to detect skin diseases, including melanoma, eczema, and psoriasis. Mobile apps powered by AI allow users to perform preliminary skin assessments, improving early diagnosis and treatment accessibility. AI enhances eye disease diagnosis by analyzing retinal scans to detect conditions such as diabetic retinopathy, glaucoma, and macular degeneration. AI-driven eye screening tools provide quick and accurate results, improving early detection and intervention.
Additionally, multiple factors are driving the adoption of AI in diagnostics. The rapid development of deep learning, computer vision, and natural language processing (NLP) has significantly improved the accuracy and efficiency of AI-driven diagnostic tools. AI automates image analysis and decision-making processes by addressing the global shortage of skilled radiologists, pathologists, and other diagnostic specialists.
In Canada, the government’s $196.1 billion investment over ten years, including $46.2 billion in new funding for provinces and territories, will significantly enhance healthcare infrastructure, digital health initiatives, and AI-driven diagnostics. This investment will promote early disease detection, predictive analytics, and AI-powered imaging solutions, improving patient outcomes and reducing diagnostic delays. Additionally, the $2.5 billion allocation for Indigenous healthcare will expand AI-based telemedicine and remote diagnostics, ensuring equitable access to advanced healthcare technologies across underserved communities.
List of Key Companies Profiled
- Siemens Healthineers AG (Siemens AG)
- Zebra Technologies Corporation
- GE HealthCare Technologies, Inc.
- F.Hoffmann-La Roche Ltd.
- Microsoft Corporation
- NVIDIA Corporation
- IBM Corporation
- DeepScribe Inc.
- AliveCor, Inc.
- Digital Diagnostics, Inc. (3Derm Systems, Inc.)
Market Report Segmentation
By Component
- Software
- Hardware
- Services
By Diagnosis
- Neurology
- Radiology
- Chest & Lung
- Oncology
- Cardiology
- Pathology
- Other Diagnosis
By Country
- US
- Canada
- Mexico
- Rest of North America
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. Competition Analysis - Global
Chapter 5. North America Artificial Intelligence in Diagnostics Market by Component
Chapter 6. North America Artificial Intelligence in Diagnostics Market by Diagnosis
Chapter 7. North America Artificial Intelligence in Diagnostics Market by Country
Chapter 8. Company Profiles
Companies Mentioned
- Siemens Healthineers AG (Siemens AG)
- Zebra Technologies Corporation
- GE HealthCare Technologies, Inc.
- F. Hoffmann-La Roche Ltd.
- Microsoft Corporation
- NVIDIA Corporation
- IBM Corporation
- DeepScribe Inc.
- AliveCor, Inc.
- Digital Diagnostics, Inc. (3Derm Systems, Inc.)
Methodology
LOADING...
